chr8-31032761-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001323311.2(PURG):c.22G>A(p.Gly8Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000834 in 1,438,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000085 ( 0 hom. )
Consequence
PURG
NM_001323311.2 missense
NM_001323311.2 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 6.78
Genes affected
PURG (HGNC:17930): (purine rich element binding protein G) The exact function of this gene is not known, however, its encoded product is highly similar to purine-rich element binding protein A. The latter is a DNA-binding protein which binds preferentially to the single strand of the purine-rich element termed PUR, and has been implicated in the control of both DNA replication and transcription. This gene lies in close proximity to the Werner syndrome gene, but on the opposite strand, on chromosome 8p11. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10716352).
BS2
High AC in GnomAdExome4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PURG | NM_001323311.2 | c.22G>A | p.Gly8Arg | missense_variant | 2/2 | ENST00000523392.2 | |
PURG | NM_013357.2 | c.22G>A | p.Gly8Arg | missense_variant | 1/1 | ||
PURG | NM_001015508.3 | c.22G>A | p.Gly8Arg | missense_variant | 1/2 | ||
PURG | NM_001323312.2 | c.22G>A | p.Gly8Arg | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PURG | ENST00000523392.2 | c.22G>A | p.Gly8Arg | missense_variant | 2/2 | 3 | NM_001323311.2 | P1 | |
PURG | ENST00000339382.3 | c.22G>A | p.Gly8Arg | missense_variant | 1/2 | 1 | |||
PURG | ENST00000475541.2 | c.22G>A | p.Gly8Arg | missense_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150918Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
150918
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000608 AC: 5AN: 82304Hom.: 0 AF XY: 0.0000245 AC XY: 1AN XY: 40836
GnomAD3 exomes
AF:
AC:
5
AN:
82304
Hom.:
AF XY:
AC XY:
1
AN XY:
40836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000855 AC: 11AN: 1287264Hom.: 0 Cov.: 32 AF XY: 0.00000642 AC XY: 4AN XY: 622820
GnomAD4 exome
AF:
AC:
11
AN:
1287264
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
622820
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150918Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73706
GnomAD4 genome
AF:
AC:
1
AN:
150918
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73706
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.22G>A (p.G8R) alteration is located in exon 1 (coding exon 1) of the PURG gene. This alteration results from a G to A substitution at nucleotide position 22, causing the glycine (G) at amino acid position 8 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
MutationTaster
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Pathogenic
D;D;.
Sift4G
Uncertain
D;D;.
Polyphen
B;B;.
Vest4
MutPred
Gain of methylation at G8 (P = 0.0024);Gain of methylation at G8 (P = 0.0024);Gain of methylation at G8 (P = 0.0024);
MVP
MPC
1.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at